▽Orange Book Blog
●11/17 18:47
November 14, 2024Federal Circuit grapples with scope of Orange Book listingsAs readers of this blog surely known, parties seeking to launch a generic drug must address the patents listed in the Orange Book for the reference listed drug. Listing of a patent in the Orange Book is a powerful tool for pharmaceutical patent owners, as it gives the right to an automatic 30 month stay against generic c

▽Clinical Trials Advisor
●11/17 12:26
CTMS Study Build and Support

▽Pharma Marketing Blog
●11/16 22:43
Email ThisBlogThis!Share to XShare to FacebookShare to PinterestEmail ThisBlogThis!Share to XShare to FacebookShare to PinterestEmail ThisBlogThis!Share to XShare to FacebookShare to PinterestEmail ThisBlogThis!Share to XShare to FacebookShare to PinterestEmail ThisBlogThis!Share to XShare to FacebookShare to Pinterest

▽Pharmafocus.com Newsfeed
●11/16 09:47
NICE gives positive recommendation for Santen’s RoclandaThe National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Santen’s Roclanda (netarsudil 0.02% and latanoprost 0.005%) as an option for patients suffering from primary open-angle glaucoma (poag) or ocular hypertension.CHMP adopts positive opinion for new breast cancer drug, Kisquali, from NovartisL

▽THE PETER ROST BLOG
●11/13 23:10
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest